< Back to all Breaking News
ATNM
7/23/2019 08:07am
Actinium Pharma achieves 50% patient enrollment for Phase 3 Sierra trial
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.